Woodline Partners’s Monte Rosa Therapeutics GLUE Stock Holding History

Woodline Partners’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.23M	Buy
2023 Q1	–	Sell
2022 Q4	$3.89M	Buy
2022 Q3	$4.11M	Buy
2022 Q2	$3.64M	Buy
2022 Q1	$674K	Buy
2021 Q4	$981K	Sell
2021 Q3	$2.99M	Sell
2021 Q2	$4.72M	Buy